The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) is pleased to announce the closing of its previously announced brokered and non-brokered private placements. TGOD has issued 67,878,788 Units (the “Units”) at a price of $1.65 per Unit, for gross proceeds of $112,000,000. Each Unit consists of one common share of the Company (a “Common Share”) and one-half common share purchase warrant of the Company (a “Warrant”). Each whole Warrant is exercisable into one Common Share (the “Warrant Share”) at the exercise price of $3.00 per share and has an expiry date that is the earlier of (a) 36 months from the date the Common Shares commence trading on a recognized stock exchange (the “Listing Date”), and (b) February 28, 2021. The Company will make all reasonable efforts to ensure the Warrants are listed on the same exchange on which the Common Shares are listed.

The Company is pleased to announce the closing of Aurora Cannabis Inc.’s (TSX:ACB) strategic investment into TGOD. The investment consists of 33,333,334 Units, priced at $1.65 per Unit, for gross proceeds of $55 million.
To date, the Company has raised a total of $160 million, fully funding the expansion of 970,000 sq. ft. state-of-the-art, ultra-high technology hybrid greenhouse facilities in Ancaster, Ontario and Valleyfield, Quebec. TGOD’s expansion and strategic partnership with Aurora positions the Company as an industry leader and sets the foundation for the highly anticipated upcoming 2018 IPO.
Upon completion of the Company’s expansion, it is expected to be one of the largest and most technologically advanced cannabis production facilities in the world, producing ultra-low cost, premium-quality organic cannabis. Additionally, TGOD’s facilities will be LEED certified and operating with close to a zero-carbon footprint with some of the lowest-cost power rates in the country.
LEED, stands for “Leadership in Energy and Environmental Design”, is an internationally recognized green building certification system, providing third-party verification that a building was designed and built using strategies aimed at improving performance across all the metrics that matter most: energy savings, water efficiency, CO2 emissions reduction, improved indoor environmental quality, and stewardship of resources and sensitivity to their impacts.
In addition to Aurora’s investment in TGOD, the companies shall enter into a supply agreement, providing Aurora with the right to purchase up to 20% of TGOD’s annual production of premium high quality organic cannabis.
Further, Aurora and Aurora Larssen Projects Inc. (“ALPS”) will provide additional services to TGOD on the completion and commissioning of its Ancaster and Valleyfield facilities, which are anticipated for Winter 2018. The facilities, when completed, will have an annual productive capacity of 116,000 kg of premium, high quality organic cannabis.
“Teaming up with Aurora, the industry’s innovation leader, provides us with a stable, supportive shareholder, through whom we have access to best-in-class technologies and industry know-how. This will significantly accelerate our time to market and establish TGOD as the world’s leading provider of premium organic cannabis,” said Csaba Reider, President of TGOD.
“The supply agreement with Aurora validates our strategy to produce premium priced organic cannabis. With this significant cornerstone investor and customer, we will be able to leverage our deep consumer packaged goods and brand building experience, as well as Aurora`s well-established brand recognition to pursue rapid growth,” said Mr. Reider.
Rob Anderson, TGOD chief executive officer, added: “Partnering with the industry leader in terms of innovation and execution validates how TGOD’s differentiated business model creates substantial value for our partners and shareholders. This is a synergistic partnership that will help TGOD reach an international audience with its premium products and rapidly capture market share in this incredibly dynamic market, and will provide further differentiation and diversification to Aurora’s product offering. We look forward to working with the teams at ALPS and Aurora as we execute on our de-risked but aggressive growth strategy.”
Investors looking to learn more about TGOD may visit the Company’s Investor Centre at https://tgod.ca/investor-centre/ or contact the Company at invest@tgod.ca; and patients may now register for the Company’s beta patient program at https://tgod.ca/patients/
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. produces Farm Grown, Pharma Grade Organic Cannabis.
The Company grows high quality, organic medical cannabis with sustainable, all natural principles. The Green Organic Dutchman Holdings Ltd. products are laboratory tested to ensure patients have access to a standardized, safe and consistent product.
TGOD has a funded capacity of 116,000 kg and is situated on 175 acres of land between two of the most populated areas of Canada: Ontario & Quebec. TGOD owns one of the largest land packages in Canada with some of the lowest power rates in the country. The Company is building a combined 970,000 sq. ft. facility capable of producing 116,000 kg of premium, high quality, organic cannabis. To date, the Company has raised $160 million dollars and has over 4,000 shareholders.
The Green Organic Dutchman Holdings Ltd. is licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Green Organic Dutchman Holdings Ltd. carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
This news release contains forward-looking information, which includes known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors — including the availability of funds, the results of financing efforts and the parties’ due diligence reviews, and general market conditions — that could cause actual results to differ materially from the Company’s expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT INFORMATION
Investor Relations
Email: invest@tgod.ca
Phone: 1 (905) 304-4201
www.tgod.ca
Click here to connect The Green Organic Dutchman Holdings Ltd. for an Investor Presentation.


Source: globenewswire.com

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less